Compendium of Cancer Genome Aberrations

HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 667: Line 667:
|
|
|
|
|
|
|
|-
|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma
|Disease
|
|
|
|
|
|GC
|
|
|
|-
|IgG4-related disease
|Disease
|
|
|
|
|
|GC
|
|
|
|-
|Unicentric Castleman disease
|Disease
|
|
|
|
|
|GC
|
|
|
|-
|Idiopathic multicentric Castleman disease
|Disease
|
|
|
|
|
|GC
|
|
|
|-
|KSHV/HHV8-associated multicentric Castleman disease
|Disease
|Sudha Arumugam, MD
|
|
|
|
|GC
|
|
|
|
Line 683: Line 743:
|
|
|-
|-
|CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS)
|
|
|
|
----<br />
|
|
----<br />
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
Line 697: Line 851:
|
|
|-
|-
|CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
|
|
|
|
----<br />
|
|
----<br />
|
|
|
|
|
Line 711: Line 863:
|
|
|-
|-
|CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)
|
|
|
|
----<br />
|
|
----<br />
|
|
|
|
|
Line 725: Line 875:
|
|
|-
|-
|CHAPTER 7 (GENETIC TUMOUR SYNDROMES)
|
|
|
|
----<br />
|
|
----<br />
|
|
|
|
|
Line 751: Line 899:
|
|
|-
|-
|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma||Disease|| || || || || ||GC||
| || || || || || || || ||
| ||
| ||
|-
|-
|IgG4-related disease||Disease|| || || || || ||GC||
| || || || || || || || ||
| ||
| ||
|-
|-
|Unicentric Castleman disease||Disease|| || || || || ||GC||
| || || || || || || || ||
| ||
| ||
|-
|-
|Idiopathic multicentric Castleman disease||Disease|| || || || || ||GC||
| || || || || || || || ||
| ||
| ||
|-
|-
|KSHV/HHV8-associated multicentric Castleman disease||Disease||Sudha Arumugam, MD|| || || || ||GC||
| || || || || || || || ||
| ||
| ||
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
|
|
----<br />
|
----<br />
|
|
|
|
|
|
|
|-
|CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)
|
|
----<br />
|
----<br />
|
|
|
|
|
|
|
|-
|CHAPTER 7 (GENETIC TUMOUR SYNDROMES)
|
|
----<br />
|
----<br />
|
|
|
|
|
|
|
|-
|-
|Diffuse large B-cell lymphoma, NOS||Disease||Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center|| || || || ||GC||
|Diffuse large B-cell lymphoma, NOS||Disease||Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center|| || || || ||GC||
Line 853: Line 1,091:
| ||
| ||
|-
|-
|B-lymphoblastic leukaemia/lymphoma
|Disease
|
|
|
|
Line 858: Line 1,098:
|
|
|
|
|
|Holli Drendel (HD)
|
|
|
|
|
|
|
|
|-
|-
| || || || || || || || ||
|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy||Disease||Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG|| || || || ||HD||
| ||
| ||
|-
|-
| || || || || || || || ||
|B-lymphoblastic leukaemia/lymphoma with hypodiploidy||Disease||Ashwini Yenamandra PhD FACMG  Lisa Smith PhD FACMG  Yassmine Akkari PhD FACMG|| || || || ||HD||
| ||
| ||
|-
|-
| || || || || || || || ||
|B-lymphoblastic leukaemia/lymphoma with iAMP21||Disease||Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte|| || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion||Disease||Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG|| || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features||Disease||Mark G. Evans, MD, University of California, Irvine  Fabiola Quintero-Rivera, MD, University of California, Irvine|| || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement||Disease||Yassmine Akkari  Nicolas Millan|| || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion||Disease||Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG  Cancer Category/Type    B-Lymphoblastic Leukemia/Lymphoma|| || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features||Disease|| || || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion||Disease||Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO|| || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion||Disease||Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO|| || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion||Disease|| || || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations||Disease|| || || || || ||HD
|
| ||
| ||
|-
|-
| || || || || || || || ||
|B-lymphoblastic leukaemia/lymphoma, NOS||Disease|| || || || || ||HD
|
| ||
| ||
|-
|-
Retrieved from "https://test.ccga.io/index.php/HAEM5:Volunteer_Assignments_and_Opportunities"